Viewing StudyNCT04785326



Ignite Creation Date: 2024-05-06 @ 3:52 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04785326
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2021-03-03

Brief Title: Efficacy Safety and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: Dong-A ST Co Ltd
Organization: Dong-A ST Co Ltd

Organization Data

Organization: Dong-A ST Co Ltd
Class: INDUSTRY
Study ID: DMB-3115-2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dong-A ST Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Meiji Seika Pharma Co Ltd INDUSTRY